share_log

Cingulate | 8-K: Current report

Cingulate | 8-K: Current report

Cingulate | 8-K：重大事件
美股SEC公告 ·  03/18 07:14

Moomoo AI 已提取核心信息

On March 18, 2024, Cingulate Inc., a company listed on the Nasdaq Capital Market under the symbol CING, announced an increase in the maximum aggregate offering price of its common stock from $4,970,000 to $8,470,000. This adjustment was made under the At The Market Offering Agreement with H.C. Wainwright & Co., which was originally dated January 3, 2023. The company has also filed a prospectus supplement for an additional $3,500,000 in shares. Previously, Cingulate Inc. had sold shares totaling $4,969,120 under the same agreement. Concurrently, the company has received a waiver from a February 2024 offering purchaser, leading to an amendment in the exercise price and term of Series A and Series B Warrants issued in September 2023. The exercise price for these warrants has been reduced to $1.13, and the exercise terms have been extended to March 17, 2029, for Series A Warrants, and to March 17, 2026, for Series B Warrants.
On March 18, 2024, Cingulate Inc., a company listed on the Nasdaq Capital Market under the symbol CING, announced an increase in the maximum aggregate offering price of its common stock from $4,970,000 to $8,470,000. This adjustment was made under the At The Market Offering Agreement with H.C. Wainwright & Co., which was originally dated January 3, 2023. The company has also filed a prospectus supplement for an additional $3,500,000 in shares. Previously, Cingulate Inc. had sold shares totaling $4,969,120 under the same agreement. Concurrently, the company has received a waiver from a February 2024 offering purchaser, leading to an amendment in the exercise price and term of Series A and Series B Warrants issued in September 2023. The exercise price for these warrants has been reduced to $1.13, and the exercise terms have been extended to March 17, 2029, for Series A Warrants, and to March 17, 2026, for Series B Warrants.
2024年3月18日，在纳斯达克资本市场上市的股票代码为CING的公司Cingulate Inc. 宣布将其普通股的最高总发行价从497万美元提高至847万美元。此次调整是根据与H.C. Wainwright & Co. 签订的市场发行协议进行的，该协议最初日期为2023年1月3日。该公司还提交了额外35万美元股票的招股说明书补充文件。此前，Cingulate Inc.根据同一协议出售了总额为4,969,120美元的股票。同时，该公司已收到2024年2月发行购买者的豁免，导致2023年9月发行的A系列和B系列认股权证的行使价和期限有所修改。这些认股权证的行使价已降至1.13美元，A系列认股权证的行使期限已延长至2029年3月17日，B系列认股权证的行使期限延长至2026年3月17日。
2024年3月18日，在纳斯达克资本市场上市的股票代码为CING的公司Cingulate Inc. 宣布将其普通股的最高总发行价从497万美元提高至847万美元。此次调整是根据与H.C. Wainwright & Co. 签订的市场发行协议进行的，该协议最初日期为2023年1月3日。该公司还提交了额外35万美元股票的招股说明书补充文件。此前，Cingulate Inc.根据同一协议出售了总额为4,969,120美元的股票。同时，该公司已收到2024年2月发行购买者的豁免，导致2023年9月发行的A系列和B系列认股权证的行使价和期限有所修改。这些认股权证的行使价已降至1.13美元，A系列认股权证的行使期限已延长至2029年3月17日，B系列认股权证的行使期限延长至2026年3月17日。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间